Inhaled insulin approved by FDA

June 28, 2014 8:02 PM

5 0

The U.S. Food and Drug Administration (FDA) announced on June 27 that it had approved a new diabetes treatment option called Afrezza. This is a novel treatment because it is a fast-acting, inhaled insulin. Afrezza just needs to be administered at the start of every meal, or within 20 minutes of starting. It is, however, […]

The U.S. Food and Drug Administration (FDA) announced on June 27 that it had approved a new diabetes treatment option called Afrezza. This is a novel treatment because it is a fast-acting, inhaled insulin. Afrezza just needs to be administered at the start of every meal, or within 20 minutes of star...

Read more

To category page

Loading...